Kamunting Street Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-275,506
| Closed | -$1.11M | – | 36 |
|
|
2022
Q2 | $1.11M | Sell |
275,506
-94,122
| -25% | -$379K | 1.5% | 11 |
|
|
2022
Q1 | $1.83M | Sell |
369,628
-58,299
| -14% | -$289K | 2.28% | 8 |
|
|
2021
Q4 | $2.98M | Sell |
427,927
-364,497
| -46% | -$2.54M | 2.21% | 10 |
|
|
2021
Q3 | $7.92M | Buy |
792,424
+168,223
| +27% | +$1.68M | 3.54% | 9 |
|
|
2021
Q2 | $8.85M | Buy |
624,201
+187,894
| +43% | +$2.66M | 3.58% | 6 |
|
|
2021
Q1 | $7.16M | Buy |
436,307
+366,806
| +528% | +$6.02M | 2.83% | 10 |
|
|
2020
Q4 | $1.44M | Sell |
69,501
-24,086
| -26% | -$499K | 0.75% | 29 |
|
|
2020
Q3 | $712K | Buy |
+93,587
| New | +$712K | 0.45% | 25 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 43 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 45 |
|